The Alexandria Venture Investments-backed genetic disease therapy developer is floating above its range having increased the number of shares in the offering.

Alphabet, Telstra and RackSpace-backed endpoint cybersecurity technology producer CrowdStrike will float above a range it had already increased.

CyberAgent, GMO, Japan Post, Nikkei, Nippon Life, Recruit and Salesforce-backed Sansan priced its shares at the top of its range today and will raise $360m including the over-allotment option.

Personalis has filed to list on the Nasdaq Global Market through an offering that would come eight years after the genome sequencing platform was spun out of Stanford University.

The Telstra and Telkom-backed enterprise messaging software provider priced its shares at the foot of the IPO's range but is in line to raise $32.5m when it floats next month.

Ideaya priced its shares below their range to raise $50m, providing exits for Alphabet, WuXi AppTec, Celgene, Roche and Novartis.

GlaxoSmithKline, Novartis and Astellas are among the investors to have celebrated an exit after cancer therapy developer Bicycle secured $60.7m in its initial public offering.

Cambridge Innovation Capital has celebrated an exit as Bicycle Therapeutics successfully lists in the US.

The O'Reilly Media, Deutsche Telekom and Swisscom-backed content delivery software provider floated at the top of its range and popped on its first day of trading.

Alexandria Real Estate Equities-backed Applied Therapeutics has gone public despite having to drastically cut its expectations for the offering.